| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.01T | 2.16T | 2.32T | 2.55T | 2.50T |
| Gross Profit | 446.14B | 405.71B | 347.89B | 330.83B | 431.72B |
| EBITDA | 90.26B | 112.39B | -60.55B | 64.08B | 157.12B |
| Net Income | 50.30B | 36.09B | -149.98B | -260.84B | 73.99B |
Balance Sheet | |||||
| Total Assets | 1.43T | 1.45T | 1.59T | 1.77T | 1.96T |
| Cash, Cash Equivalents and Short-Term Investments | 239.49B | 279.31B | 227.13B | 262.06B | 287.36B |
| Total Debt | 438.90B | 521.35B | 589.86B | 725.59B | 626.57B |
| Total Liabilities | 1.14T | 1.29T | 1.43T | 1.55T | 1.49T |
| Stockholders Equity | 283.07B | 154.65B | 143.18B | 208.74B | 454.57B |
Cash Flow | |||||
| Free Cash Flow | -23.32B | -40.61B | 71.92B | -42.27B | 12.08B |
| Operating Cash Flow | -202.52M | -1.59B | 124.50B | 14.75B | 75.16B |
| Investing Cash Flow | 76.02B | 103.74B | 10.88B | -40.97B | -31.45B |
| Financing Cash Flow | -112.18B | -74.77B | -149.67B | -18.48B | -124.29B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
62 Neutral | $1.78B | 75.53 | 5.99% | ― | -0.22% | ― | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
59 Neutral | $259.60M | 291.90 | 1.02% | ― | -21.70% | -93.37% | |
58 Neutral | $122.70B | -60.72 | -4.05% | 0.41% | -2.74% | -126.37% | |
46 Neutral | $2.49B | 8.13 | 20.55% | ― | -11.33% | 36.22% | |
45 Neutral | $4.66B | -85.30 | -1.24% | ― | -9.90% | 97.79% | |
43 Neutral | $73.99M | -0.12 | -18.46% | ― | 50.67% | 49.50% |